Log in to save to my catalogue

Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respirato...

Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respirato...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a315c29b5364d6da9023a1485e4aecf

Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respiratory syncytial virus infection

About this item

Full title

Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respiratory syncytial virus infection

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-06, Vol.14 (1), p.13928-18, Article 13928

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Respiratory syncytial virus is the major cause of acute lower respiratory tract infections in young children, causing extensive mortality and morbidity globally, with limited therapeutic or preventative options. Cathelicidins are innate immune antimicrobial host defence peptides and have antiviral activity against RSV. However, upper respiratory tr...

Alternative Titles

Full title

Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respiratory syncytial virus infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7a315c29b5364d6da9023a1485e4aecf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a315c29b5364d6da9023a1485e4aecf

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-64446-1

How to access this item